Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment

Recombinant antibodies such as nanobodies are progressively demonstrating to be a valid alternative to conventional monoclonal antibodies also for clinical applications. Furthermore, they do not solely represent a substitute for monoclonal antibodies but their unique features allow expanding the app...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiewen, Kang, Guangbo, Yuan, Haibin, Cao, Xiaocang, Huang, He, de Marco, Ario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804282/
https://www.ncbi.nlm.nih.gov/pubmed/35116045
http://dx.doi.org/10.3389/fimmu.2021.838082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804282/
https://www.ncbi.nlm.nih.gov/pubmed/35116045
http://dx.doi.org/10.3389/fimmu.2021.838082

Ejemplares similares